Related Experiment Video
Updated: Sep 23, 2025
06:51
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.1K
The Tumor Suppressor Kinase LKB1: Metabolic Nexus
Mohammed Bourouh1, Paola A Marignani1
1Department of Biochemistry and Molecular Biology, Faculty of Medicine, Dalhousie University Halifax, Halifax, NS, Canada.
Frontiers in Cell and Developmental Biology
|May 16, 2022
Summary
Loss of Liver kinase B1 (LKB1), a tumor suppressor, fuels cancer growth and limits treatment options. New insights reveal LKB1
Area of Science:
- Oncology
- Molecular Biology
- Metabolic Regulation
Background:
- Liver kinase B1 (LKB1) is a critical tumor suppressor kinase involved in multiple cancers, including lung, gastrointestinal, pancreatic, and breast malignancies.
- LKB1 is known for its role in activating AMP-activated protein kinase (AMPK) during energy stress, regulating cellular metabolism.
- Loss or inactivation of LKB1 is linked to Peutz-Jeghers syndrome (PJS) and promotes cancer cell metabolic reprogramming, enhancing growth and division.
Purpose of the Study:
- To review the tumor-suppressive functions of LKB1.
- To elucidate the impact of LKB1 loss on metabolic reprogramming in cancer cells, with a specific focus on lung cancer.
- To discuss emerging therapeutic strategies targeting metabolic vulnerabilities in LKB1-mutant tumors.
Main Methods:
- Literature review of studies on LKB1 function in cancer.
- Analysis of the role of LKB1 in metabolic regulation and adaptation.
- Exploration of therapeutic targets for LKB1-deficient cancers.
Main Results:
- LKB1 inactivation promotes metabolic reprogramming, supporting increased cancer cell proliferation and aggressiveness.
- LKB1 loss leads to altered metabolic pathways that can be exploited for therapeutic intervention.
- Specific focus on lung cancer highlights the significant impact of LKB1 status on disease progression.
Conclusions:
- LKB1 plays a crucial role in preventing cancer by maintaining metabolic homeostasis.
- Targeting aberrant metabolic pathways in LKB1-mutant cancers presents a promising therapeutic avenue.
- Further research into LKB1's metabolic functions may uncover novel strategies for treating various malignancies.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:22PI3K/mTOR/AKT Signaling Pathway
4.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.1K
02:53Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
01:19Interactions Between Signaling Pathways
6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:19Regulation of Metabolism
10.0K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
10.0K